← FDA DRUG APPROVALS

FDA ANDA · ANDA200981

METOPROLOL TARTRATE

Sponsor: RUBICON RESEARCH

APPLICATION
ANDA200981
TYPE
ANDA
ORIGINAL APPROVAL
2014-10-28
LATEST ACTION
2025-05-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METOPROLOL TARTRATEPrescription
METOPROLOL TARTRATE 75MG · TABLET · ORAL
METOPROLOL TARTRATEPrescription
METOPROLOL TARTRATE 100MG · TABLET · ORAL
METOPROLOL TARTRATEPrescription
METOPROLOL TARTRATE 25MG · TABLET · ORAL
METOPROLOL TARTRATEPrescription
METOPROLOL TARTRATE 37.5MG · TABLET · ORAL
METOPROLOL TARTRATEPrescription
METOPROLOL TARTRATE 50MG · TABLET · ORAL

Approval history

2025-05-22Labeling · Supplement 48 · standardAP
2019-05-03Labeling · Supplement 14 · standardAP
2016-11-30Labeling · Supplement 7 · standardAP
2014-10-28Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →